Gujarat Fluorochemicals FY26 Annual Earnings Summary
4 quarters covered · ₹4,996 Cr revenue · ₹574 Cr PAT · 26.0% average EBITDA margin.
Quarter-by-quarter progression
Management promises made during the year
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q2 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q3 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY26Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
Q4 FY26Risks flagged during the year
Higher US tariffs have caused customers to delay buying decisions, impacting fluoropolymer sales. Management is exploring alternative markets but tariff persistence could weigh on growth.
Q3 FY26 · highR22 prices continue to decline, and production quota reductions are limiting volumes, impacting refrigerant segment profitability.
Q4 FY26 · highHeightened geopolitical tensions and volatile energy prices have increased input and logistics costs, impacting margins.
Q1 FY26 · mediumUS imposed additional 15% duty on select new fluoropolymers; management believes demand is inelastic and pass-through possible, but risk remains if customers resist.
Q1 FY26 · mediumAnalyst questioned if R32 prices could normalize like R125; management cited different fundamentals but acknowledged difficulty in projecting prices.
Q1 FY26 · mediumBattery chemicals revenue still negligible; management expects meaningful revenue only in FY27, posing risk if qualifications or demand take longer.
Q2 FY26 · mediumA fire incident at the R32 plant has temporarily halted production. While management expects restart by end of November, any further delays could impact the 20,000 MT target.
Q2 FY26 · mediumCustomer qualification for battery materials is a lengthy process. Management did not provide a specific timeline for commercial sales, creating uncertainty around revenue visibility.
Q2 FY26 · mediumWorking capital days have increased to ~182 from 120 in FY22, partly due to inventory for export depots and EV samples. Management expects improvement only after full-scale operations.
Q3 FY26 · mediumR32 production startup delayed by a quarter, pushing expected revenue contribution to Q4 FY26, which may pressure near-term earnings.
Q3 FY26 · mediumFinance ministry did not accept DGTR's anti-dumping duty recommendation, impacting domestic fluoropolymer volumes and growth trajectory.
Q3 FY26 · mediumLFP CAM and binder qualifications are progressing slower than expected, with commercial revenues only expected in H2 FY27, risking revenue targets.
What changed through the year
Q1 FY26 · Fluoropolymer segment 25% revenue growth for FY26
Management reiterated 25% growth guidance for fluoropolymer business, driven by new approvals and legacy player exit.
Q1 FY26 · R32 capacity to reach 20,000 MT by end of FY26
R32 capacity to be ramped up to 20,000 metric tons in phases by end of this financial year via retrofitting.
Q1 FY26 · Battery materials revenue to trickle in from H2 FY26, meaningful in FY27
Revenue from battery chemicals expected to start in second half of FY26, with significant ramp-up in FY27.
Q1 FY26 · Capex of 1,200 crore in EV business in FY26
Planned capex of 1,200 crore for battery materials business in FY26, on track as per plan.
Q2 FY26 · R32 capacity target of 20,000 MT by March 2026
Management reaffirmed the target to achieve 20,000 MT R32 capacity by end of FY26, with plant restart expected by end of November 2025.
Q2 FY26 · Battery materials revenue to start in Q4 FY26
Revenue from EV materials business is expected to begin flowing from Q4 of the current financial year.
Q2 FY26 · Battery materials EBITDA breakeven in FY27
Management expects the battery chemicals business to reach EBITDA breakeven in FY27.
Q2 FY26 · Capex of ~₹1,500 crore for battery materials in FY27
Capex for battery materials is expected to be around ₹1,500 crore in FY27, part of the ₹6,000 crore 4-5 year plan.
Q3 FY26 · R32 capacity to reach 20,000 tons by Q1 FY27
Phase 1 R32 capacity of 20,000 tons will be commissioned early in calendar year 2026, delayed from March 2026 due to safety audits.
Q3 FY26 · Battery materials capacities fully utilized by end of FY27
Current LiPF6, LFP CAM, and binder capacities expected to be fully utilized by end of FY27, with revenue ramp-up starting in FY27.
Q3 FY26 · Working capital days target of 170-180
Management targets reducing inventory days from current 201 to 170-180 in the coming year.
Q3 FY26 · Oman battery materials plant commissioning in 18 months
Greenfield project in Oman with $216M investment expected to be commissioned in 18 months (mid to end CY27).
Q4 FY26 · Fluoropolymer volume growth of 15-20% in FY27
Management guided 15-20% volume growth in fluoropolymer products for FY27, driven by semiconductor and clean energy demand.
Q4 FY26 · R32 capacity to reach 20,000 tons by H2 FY27
R32 capacity will be ramped up to 20,000 tons by the second half of FY27; 10,000 tons already operational.
Q4 FY26 · Battery materials revenue to reach three-digit crore by Q4 FY27
Battery materials revenue expected to reach a high three-digit crore number by Q4 FY27, with significant QoQ growth.
Q4 FY26 · Battery materials EBITDA margin target of 25%+ by FY29
Management reiterated target of 25%+ EBITDA margins for battery materials by FY29, with 2x asset turns.